Inflammatory networks during cellular senescence: causes and consequences

Trends in Molecular Medicine

Volumn 16, Issue 5, 2010, Pages 238-246

  Freund, Adam ^a,b   Orjalo, Arturo V ^a   Desprez, Pierre Yves ^a,c   Campisi, Judith ^a,d  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCL1 CHEMOKINE; CXCL1 CHEMOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; SOMATOMEDIN C; STROMELYSIN; STROMELYSIN 2; TUMOR NECROSIS FACTOR ALPHA; MICRORNA; TRANSCRIPTION FACTOR;

AGING; B LYMPHOCYTE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; DNA DAMAGE; DNA REPAIR; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; INFLAMMATION; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTE; PHENOTYPE; REVIEW; SENESCENCE; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VEIN DILATATION; ANIMAL; BIOLOGICAL MODEL; CELL AGING; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL AGING; HUMANS; INFLAMMATION; MICRORNAS; MODELS, BIOLOGICAL; TRANSCRIPTION FACTORS;

EID: 77952105389     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.03.003     Document Type: Review

References (77)

1. Sarkar D., and Fisher P.B. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 236 (2006) 13-23
2. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
3. Vasto S., et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 128 (2007) 83-91
4. Ferrucci L., et al. A flame burning within. Aging Clin. Exp. Res. 16 (2004) 240-243
5. Bruunsgaard H. The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. Dan. Med. Bull. 53 (2006) 285-309
6. Maggio M., et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 575-584
7. Franceschi C., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 (2007) 92-105
8. Brennan F.M., et al. Cytokine expression in chronic inflammatory disease. Br. Med. Bull. 51 (1995) 368-384
9. Brod S.A. Unregulated inflammation shortens human functional longevity. Inflamm. Res. 49 (2000) 561-570
10. Caruso C., et al. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 1028 (2004) 1-13
11. Kuilman T., and Peeper D.S. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9 (2009) 81-94
12. Franceschi C., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908 (2000) 244-254
13. McElhaney J.E., and Effros R.B. Immunosenescence: what does it mean to health outcomes in older adults?. Curr. Opin. Immunol. 21 (2009) 418-424
14. Campisi J. Senescent cells, tumor suppression and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
15. Parrinello S., et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118 (2005) 485-496
16. Prelog M. Aging of the immune system: a risk factor for autoimmunity?. Autoimmun. Rev. 5 (2006) 136-139
17. Gopinath S.D., and Rando T.A. Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell 7 (2008) 590-598
18. Carlson M.E., and Conboy I.M. Loss of stem cell regenerative capacity within aged niches. Aging Cell 6 (2007) 371-382
19. Mourkioti F., and Rosenthal N. IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol. 26 (2005) 535-542
20. Huang H., et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 16 (2009) 1332-1343
21. Seita J., et al. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 111 (2008) 1903-1912
22. Iliopoulos D., et al. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139 (2009) 693-706
23. Coppé, J.P. et al. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868
24. Young A.R., and Narita M. SASP reflects senescence. EMBO Rep. 10 (2009) 228-230
25. Coppé J.P., et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. Mech. Dis. 5 (2010) 99-118
26. Kumar S., et al. Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4683-4687
27. Wang S., et al. Characterization of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts. Mech. Ageing Dev. 92 (1996) 121-132
28. E600-associated senescence-like cell cycle arrest of human nevi. Nature 436 (2005) 720-724
29. Braig M., et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
30. Collado M., and Serrano M. Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer 10 (2010) 51-57
31. Ben-Porath I., and Weinberg R.A. The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 37 (2005) 961-976
32. Lombard D.B., et al. DNA repair, genome stability, and aging. Cell 120 (2005) 497-512
33. Braig M., and Schmitt C.A. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 66 (2006) 2881-2884
34. Collado M., and Serrano M. The power and the promise of oncogene-induced senescence markers. Nat. Rev. Cancer 6 (2006) 472-476
35. Campisi J., and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8 (2007) 729-740
36. Coppé J.-P., et al. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281 (2006) 29568-29574
37. Krtolica A., et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 12072-12077
38. Liu D., and Hornsby P.J. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67 (2007) 3117-3126
39. Charalambous C., et al. Glioma-associated endothelial cells show evidence of replicative senescence. Exp. Cell Res. 313 (2007) 1192-1202
40. Studebaker A.W., et al. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 68 (2008) 9087-9095
41. Xue W., et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
42. Dimri G.P., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9363-9367
43. Jeyapalan J.C., et al. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128 (2007) 36-44
44. Krizhanovsky J., et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114 (2004) 1299-1307
45. Price J.S., et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1 (2002) 57-65
46. Vasile E., et al. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15 (2001) 458-466
47. Erusalimsky J.D., and Kurz D.J. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp. Gerontol. 40 (2005) 634-642
48. Roberts S., et al. Senescence in human intervertebral discs. Eur. Spine J. 15 Suppl. 3 (2006) S312-316
49. Castro P., et al. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55 (2003) 30-38
50. Choi J., et al. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology 56 (2000) 160-166
51. Acosta J.C., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008) 1006-1018
52. Wajapeyee N., et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132 (2008) 363-374
53. Yang G., et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16472-16477
54. Kuilman T., et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133 (2008) 1019-1031
55. Krizhanovsky V., et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134 (2008) 657-667
56. Rodier F., et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11 (2009) 973-979
57. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 8 (2008) 512-522
58. Elkon R., et al. Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol. 6 (2005) R43
59. Cuenda A., and Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773 (2007) 1358-1375
60. Kwong J., et al. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J. Biol. Chem. 284 (2009) 11237-11246
61. Iwasa H., et al. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8 (2003) 131-144
62. Wang W., et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell Biol. 22 (2002) 3389-3403
63. Hiscott J., et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell Biol. 13 (1993) 6231-6240
64. Niu J., et al. Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. J. Biol. Chem. 279 (2004) 16452-16462
65. Orjalo A.V., et al. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 17031-17036
66. Naugler W.E., and Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr. Opin. Genet. Dev. 18 (2008) 19-26
67. Bhaumik D., et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 1 (2009) 402-411
68. Taganov K.D., et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12481-12486
69. Funayama R., and Ishikawa F. Cellular senescence and chromatin structure. Chromosoma 116 (2007) 431-440
70. Mehta I.S., et al. Alterations to nuclear architecture and genome behavior in senescent cells. Ann. N. Y. Acad. Sci. 1100 (2007) 250-263
71. Adams P.D. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397 (2007) 84-93
72. Narita M. Cellular senescence and chromatin organisation. Br. J. Cancer 96 (2007) 686-691
73. Horike S., et al. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37 (2005) 31-40
74. Adams P.D. Remodeling chromatin for senescence. Aging Cell 6 (2007) 425-427
75. Bavik C., et al. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res. 66 (2006) 794-802
76. Coppe J.P., et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One 5 (2010) e9188
77. West M.D., et al. Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp. Gerontol. 31 (1996) 175-193